Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2025-12-26 @ 3:13 AM
Study NCT ID:
NCT03488160
Status:
UNKNOWN
Last Update Posted:
2018-04-10
First Post:
2018-03-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CAR-T Treatment for Relapse / Refractory Type Safety and Effectiveness of Lymphoma
Sponsor:
Sinobioway Cell Therapy Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-04-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2019-04-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2019-04-20
Completion Date Type:
ESTIMATED
First Submit Date:
2018-03-26
First Submit QC Date:
None
Study First Post Date:
2018-04-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-04-07
Last Update Post Date:
2018-04-10
Last Update Post Date Type:
ACTUAL